Skin-Directed Tactics Optimal for Early Cutaneous Lymphoma

The many first-line treatments for this rare malignancy are being assessed in the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) trial.
Medscape Medical News

http://ift.tt/2wqGzcX